Health News

Cumberland Pharmaceuticals Inc. today announced the publication of new data supporting the safety and efficacy of Caldolor® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.

Read more

Filed under: Pharmacy News
Tags: medicine, Pharmacy, Surgery

Related posts

• Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports (0)
  A newly published study in The New England Journal of Medicine shows that in premenopausal women with early breast cancer administering Zometa(R) (zoledronic acid) along with post-surgery hormone therapy provided a reduction in risk of recurrence or death that was 36% beyond that achieved with hormone therapy alone(1). Read more [tags] Pharmacy News [/tags]
  
  
• Study finds link between genetic variation and cetuximab rectal cancer therapy (0)
  team of researchers led by Keck School of Medicine of the University of Southern California (USC) oncologist Heinz-Josef Lenz, M.D., has identified a genetic marker that may predict which patients with rectal cancer can be cured by certain chemotherapies when combined with surgery. Read more [tags] Pharmacy News [/tags]
  
  
• Study describes first known case of necrotizing fasciitis from bath salts (0)
  A study led by Russell R. Russo, MD, a third-year Orthopaedic Surgery resident at LSU Health Sciences Center New Orleans School of Medicine, has identified a new source of life-threatening necrotizing fasciitis - "bath salts." Read more [tags] Pharmacy News [/tags]
  
  
• Results In ‘The New England Journal Of Medicine’ Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery (0)
  Newly published data in The New England Journal of Medicine affirm five-year upfront use of Femara((R)) (letrozole tablets) following surgery as an optimal treatment approach versus tamoxifen for postmenopausal women with early stage breast cancer (hormone-receptor positive). Read more [tags] Pharmacy News [/tags]
  
  
• NPS RADAR Reviews Rivaroxaban - Oral Anticoagulant For Post-knee Replacement Surgery, Australia (0)
  Prescribers treating patients who have had total hip or knee replacement surgery can access an independent review of the oral anticoagulant rivaroxaban (Xarelto) in the August issue of NPS RADAR. NPS RADAR provides independent information about new medicines and changes to PBS listings to health professionals and is published to [...]